Clinical Trial Update: Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Yttrium-90 microsphere radioembolization combined with immune checkpoint inhibitors, anti-angiogenesis drugs, and sequential h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Anti-angiogenesis drugs
• Hepatic arterial infusion chemotherapy (HAIC) (hepatic arterial infusion chemotherapy)
• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• Yttrium-90 microspheres (yttrium-90 microspheres)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING